Inventor
ESMON CHARLES T
US27 patents
⚠️ This page may combine multiple inventors who share the name “ESMON CHARLES T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
OKLAHOMA MED RES FOUND
26 patentsUS5695993ADec 9, 1997
Cloning and regulation of an endothelial cell protein C/activated protein C receptor
OKLAHOMA MED RES FOUND37 citations95
US5147638ASep 15, 1992
Inhibition of tumor growth by blockade of the protein C system
OKLAHOMA MED RES FOUND76 citations95
US5847085ADec 8, 1998
Modified protein C and methods of use thereof
OKLAHOMA MED RES FOUND83 citations94
US5837843ANov 17, 1998
Modified protein C
OKLAHOMA MED RES FOUND85 citations94
US5298599AMar 29, 1994
Expression and purification of recombinant soluble tissue factor
OKLAHOMA MED RES FOUND64 citations94
US5202253AApr 13, 1993
Monoclonal antibody specific for protein C and antibody purification method
OKLAHOMA MED RES FOUND65 citations94
US5009889AApr 23, 1991
Treatment of dysfunctional vascular endothelium using activated protein C
OKLAHOMA MED RES FOUND80 citations94
US5698518ADec 16, 1997
Method for regulating inflammation and tumor growth with calmodulin, calmodulin analogues or calmodulin antagonists
OKLAHOMA MED RES FOUND72 citations91
US5472852ADec 5, 1995
Assay for detection of selective Protein C inhibition by patients
OKLAHOMA MED RES FOUND29 citations90
US5120537AJun 9, 1992
Factor xa based anticoagulant compositions
OKLAHOMA MED RES FOUND28 citations90
US5639625AJun 17, 1997
Method for detecting antibodies to thrombomodulin in patients
OKLAHOMA MED RES FOUND21 citations89
US6989241B2Jan 24, 2006
Assay for rapid detection of human activated protein C and highly specific monoclonal antibody therefor
OKLAHOMA MED RES FOUND35 citations88
US6200751B1Mar 13, 2001
Endothelial specific expression regulated by EPCR control elements
OKLAHOMA MED RES FOUND29 citations88
US6423313B1Jul 23, 2002
Inhibition of tumor growth by blockade of the protein C system
OKLAHOMA MED RES FOUND14 citations83
US7247453B1Jul 24, 2007
Calcium binding recombinant antibody against protein C
OKLAHOMA MED RES FOUND10 citations81
US5804392ASep 8, 1998
Diagnostic assays using soluble endothelial cell protein C/activated protein C receptor
OKLAHOMA MED RES FOUND15 citations79
US10350261B2Jul 16, 2019
Extracellular histones as biomarkers for prognosis and molecular targets for therapy
OKLAHOMA MED RES FOUND1 citations73
US10238711B2Mar 26, 2019
Extracellular histones as biomarkers for prognosis and molecular targets for therapy
OKLAHOMA MED RES FOUND1 citations73
US6399064B1Jun 4, 2002
Cloning and regulation of an endothelial cell protein C/activated protein C receptor
OKLAHOMA MED RES FOUND5 citations72
US5852171ADec 22, 1998
Cloning and regulation of an endothelial cell protein C/activated protein C receptor
OKLAHOMA MED RES FOUND8 citations72
US6037450AMar 14, 2000
Diagnostic assays using soluble endothelial cell protein C/activated protein C receptor
OKLAHOMA MED RES FOUND9 citations71
US5336610AAug 9, 1994
Method for purification of the zymogen of protein C or the heavy chain thereof using monoclonal antibody HPC-4
OKLAHOMA MED RES FOUND8 citations71
US6239101B1May 29, 2001
Thrombin binding polypeptides
OKLAHOMA MED RES FOUND8 citations68
US6953568B1Oct 11, 2005
Targeting of molecules to large vessel endothelium using EPCR
OKLAHOMA MED RES FOUND5 citations63
US11458187B2Oct 4, 2022
Extracellular histones as biomarkers for prognosis and molecular targets for therapy
OKLAHOMA MED RES FOUND0 citations62
US7063843B1Jun 20, 2006
Cloning and regulation of an endothelial cell protein C/activated protein C receptor
OKLAHOMA MED RES FOUND0 citations51